Rentokil Initial (RTO) Projected to Announce Earnings on Thursday

Rentokil Initial (NYSE:RTOGet Free Report) will likely be announcing its Q2 2026 resultson Thursday, July 30th. Analysts expect Rentokil Initial to post earnings of $0.6580 per share and revenue of $3.5339 billion for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, July 30, 2026 at 4:30 AM ET.

Rentokil Initial Trading Up 0.3%

NYSE:RTO opened at $28.77 on Wednesday. The firm has a 50-day simple moving average of $29.81 and a 200-day simple moving average of $31.33. Rentokil Initial has a one year low of $22.77 and a one year high of $34.67. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.16.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the company. Jane Street Group LLC boosted its stake in Rentokil Initial by 292.0% in the first quarter. Jane Street Group LLC now owns 117,341 shares of the company’s stock valued at $2,687,000 after acquiring an additional 87,405 shares in the last quarter. Creative Planning acquired a new position in shares of Rentokil Initial during the second quarter worth $393,000. JPMorgan Chase & Co. increased its position in shares of Rentokil Initial by 2,549.7% during the second quarter. JPMorgan Chase & Co. now owns 93,165 shares of the company’s stock worth $2,236,000 after purchasing an additional 89,649 shares in the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of Rentokil Initial by 40.0% during the 2nd quarter. Russell Investments Group Ltd. now owns 4,582 shares of the company’s stock valued at $110,000 after purchasing an additional 1,309 shares during the last quarter. Finally, M&T Bank Corp lifted its holdings in shares of Rentokil Initial by 19.7% during the 2nd quarter. M&T Bank Corp now owns 10,557 shares of the company’s stock valued at $253,000 after purchasing an additional 1,736 shares during the last quarter. Institutional investors own 9.91% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on RTO shares. Wall Street Zen lowered shares of Rentokil Initial from a “buy” rating to a “hold” rating in a report on Monday, July 20th. Weiss Ratings restated a “hold (c)” rating on shares of Rentokil Initial in a report on Wednesday, June 24th. Zacks Research cut Rentokil Initial from a “hold” rating to a “strong sell” rating in a research report on Monday, June 15th. Finally, The Goldman Sachs Group raised Rentokil Initial from a “neutral” rating to a “buy” rating in a research report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $34.50.

Get Our Latest Report on RTO

About Rentokil Initial

(Get Free Report)

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.

See Also

Earnings History for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.